These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 17495454
1. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions. Kanamaru Y, Blank U, Monteiro RC. Contrib Nephrol; 2007; 157():148-52. PubMed ID: 17495454 [Abstract] [Full Text] [Related]
2. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives. Ben Mkaddem S, Rossato E, Heming N, Monteiro RC. Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915 [Abstract] [Full Text] [Related]
3. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. Kanamaru Y, Pfirsch S, Aloulou M, Vrtovsnik F, Essig M, Loirat C, Deschênes G, Guérin-Marchand C, Blank U, Monteiro RC. J Immunol; 2008 Feb 15; 180(4):2669-78. PubMed ID: 18250479 [Abstract] [Full Text] [Related]
4. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffié C, Hénin D, Benhamou M, Pretolani M, Blank U, Monteiro RC. Immunity; 2005 Jan 15; 22(1):31-42. PubMed ID: 15664157 [Abstract] [Full Text] [Related]
5. IgA Fc receptor I signals apoptosis through the FcRgamma ITAM and affects tumor growth. Kanamaru Y, Tamouza H, Pfirsch S, El-Mehdi D, Guérin-Marchand C, Pretolani M, Blank U, Monteiro RC. Blood; 2007 Jan 01; 109(1):203-11. PubMed ID: 16990604 [Abstract] [Full Text] [Related]
6. IgA Fc receptors. Monteiro RC, Van De Winkel JG. Annu Rev Immunol; 2003 Jan 01; 21():177-204. PubMed ID: 12524384 [Abstract] [Full Text] [Related]
7. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC. Eur J Immunol; 2007 Apr 01; 37(4):1116-28. PubMed ID: 17393381 [Abstract] [Full Text] [Related]
8. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters. Pfirsch-Maisonnas S, Aloulou M, Xu T, Claver J, Kanamaru Y, Tiwari M, Launay P, Monteiro RC, Blank U. Sci Signal; 2011 Apr 19; 4(169):ra24. PubMed ID: 21505186 [Abstract] [Full Text] [Related]
9. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG. Brandsma AM, Bondza S, Evers M, Koutstaal R, Nederend M, Jansen JHM, Rösner T, Valerius T, Leusen JHW, Ten Broeke T. Front Immunol; 2019 Apr 19; 10():704. PubMed ID: 31031746 [Abstract] [Full Text] [Related]
10. Inhibitory ITAMs as novel regulators of immunity. Blank U, Launay P, Benhamou M, Monteiro RC. Immunol Rev; 2009 Nov 19; 232(1):59-71. PubMed ID: 19909356 [Abstract] [Full Text] [Related]
11. FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region. Posgai MT, Tonddast-Navaei S, Jayasinghe M, Ibrahim GM, Stan G, Herr AB. Proc Natl Acad Sci U S A; 2018 Sep 18; 115(38):E8882-E8891. PubMed ID: 30181292 [Abstract] [Full Text] [Related]
12. Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis. Watanabe T, Kanamaru Y, Liu C, Suzuki Y, Tada N, Okumura K, Horikoshi S, Tomino Y. Clin Exp Immunol; 2011 Nov 18; 166(2):235-50. PubMed ID: 21985370 [Abstract] [Full Text] [Related]
13. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. J Immunol; 2001 Feb 01; 166(3):1781-9. PubMed ID: 11160224 [Abstract] [Full Text] [Related]
14. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease. Aleyd E, Heineke MH, van Egmond M. Immunol Rev; 2015 Nov 01; 268(1):123-38. PubMed ID: 26497517 [Abstract] [Full Text] [Related]
15. Crystal structure of the ectodomain of human FcalphaRI. Ding Y, Xu G, Yang M, Yao M, Gao GF, Wang L, Zhang W, Rao Z. J Biol Chem; 2003 Jul 25; 278(30):27966-70. PubMed ID: 12783876 [Abstract] [Full Text] [Related]
16. IgA, IgA receptors, and their anti-inflammatory properties. Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC. Curr Top Microbiol Immunol; 2014 Jul 25; 382():221-35. PubMed ID: 25116102 [Abstract] [Full Text] [Related]
17. Pathogenic role of IgA receptors in IgA nephropathy. Monteiro RC. Contrib Nephrol; 2007 Jul 25; 157():64-9. PubMed ID: 17495439 [Abstract] [Full Text] [Related]
18. IgA-CD89 complex in IgA nephropathy: a study on molecular function. Wiwanitkit V. Ren Fail; 2006 Jul 25; 28(6):457-9. PubMed ID: 16928613 [Abstract] [Full Text] [Related]
19. The glomerular response to IgA deposition in IgA nephropathy. Moura IC, Benhamou M, Launay P, Vrtovsnik F, Blank U, Monteiro RC. Semin Nephrol; 2008 Jan 25; 28(1):88-95. PubMed ID: 18222350 [Abstract] [Full Text] [Related]
20. Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway. Rossato E, Ben Mkaddem S, Kanamaru Y, Hurtado-Nedelec M, Hayem G, Descatoire V, Vonarburg C, Miescher S, Zuercher AW, Monteiro RC. Arthritis Rheumatol; 2015 Jul 25; 67(7):1766-77. PubMed ID: 25833812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]